help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
This version published online on February 19, 2004
Molecular Endocrinology, doi:10.1210/me.2003-0432
Molecular Endocrinology Vol. 0, No. 2004 200304321-
doi:10.1210/me.2003-0432
Copyright © 2004 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
18/5/1064    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iannone, M. A.
Right arrow Articles by Pearce, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iannone, M. A.
Right arrow Articles by Pearce, K. H.

Submitted on November 5, 2003
Accepted on February 7, 2004

Correlation Between in vitro Peptide Binding Profiles and Cellular Activities for Estrogen Receptor Modulating Compounds

Marie A. Iannone, Catherine A. Simmons, Sue H. Kadwell, Daniel L. Svoboda, Dana E. Vanderwall, Su-Jun Deng, Thomas G. Consler, Jean Shearin, John G. Gray, and Kenneth H. Pearce*

Department of Gene Expression and Protein Biochemistry (M.A.I., C.A.S., S.H.K., S-J.D. T.G.C., J.S., J.G.G., K.H.P) and Department of Cheminformatics (D.L.S., D.E.V.), Discovery Research, GlaxoSmithKline, Research Triangle Park, N.C., 27709

* To whom correspondence should be addressed. E-mail: kenneth.h.pearce{at}gsk.com.

Numerous biochemical and structural studies have shown that the conformation of the estrogen receptor alpha (ER{alpha}) can be influenced by ligand binding. In turn, the conformational state of ER{alpha} affects the ability of the receptor to interact with a wide variety of protein accessory factors. To globally investigate ligand-based cofactor recruitment activities of ER{alpha}, we have applied a flow cytometric multiplexed binding assay to determine the simultaneous binding of ER{alpha} to over 50 different peptides derived from both known cofactor proteins and random peptide phage display. Using over 400 ER{alpha}-binding compounds, we have observed that the multiplexed in vitro peptide-binding profiles are distinct for a number of compounds and that these profiles can predict the effect that ER{alpha} ligands have on various cellular activities. These cell-based activities include transcriptional regulation at an estrogen response element, MCF-7 cell proliferation, and Ishikawa endometrial cell stimulation. The majority of the compound-induced diversity in the peptide profiling assay is provided by the unique phage display peptides. Importantly, some of these peptides show a sequence relationship with the corepressor motif, suggesting that peptides identified via phage display might represent natural binding partners of ER{alpha}. These in vitro:cellular correlations may in part explain tissue-specific activities of ER{alpha}-modulating compounds.
Key words: selective estrogen receptor modulator • nuclear receptor • ligand binding domain • peptide profiling • flow cytometry • fluorescent microspheres • phage display

NURSA Molecule Pages Link:

Nuclear Receptors:   DAX1  |  SHP  |  ERα
Coregulators:   RIP140  |  TRAP220  |  PGC-1  |  SRC-1  |  GRIP1  |  AIB1  |  ASC-2  |  NCOR  |  SMRT
Ligands:   17β-Estradiol  |  Diethylstilbestrol  |  4-Hydroxytamoxifen  |  Raloxifene



This article has been cited by other articles:


Home page
 EndocrinologyHome page
M. H. Hong, H. Sun, C. H. Jin, M. Chapman, J. Hu, W. Chang, K. Burnett, J. Rosen, A. Negro-Vilar, and J. N. Miner
Cell-Specific Activation of the Human Skeletal {alpha}-Actin by Androgens
Endocrinology, March 1, 2008; 149(3): 1103 - 1112.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
B. G. Shearer, D. J. Steger, J. M. Way, T. B. Stanley, D. C. Lobe, D. A. Grillot, M. A. Iannone, M. A. Lazar, T. M. Willson, and A. N. Billin
Identification and Characterization of a Selective Peroxisome Proliferator-Activated Receptor {beta}/{delta} (NR1C2) Antagonist
Mol. Endocrinol., February 1, 2008; 22(2): 523 - 529.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
W. Zwart, A. Griekspoor, M. Rondaij, D. Verwoerd, J. Neefjes, and R. Michalides
Classification of anti-estrogens according to intramolecular FRET effects on phospho-mutants of estrogen receptor {alpha}
Mol. Cancer Ther., May 1, 2007; 6(5): 1526 - 1533.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Heldring, T. Pawson, D. McDonnell, E. Treuter, J.-A. Gustafsson, and A. C. W. Pike
Structural Insights into Corepressor Recognition by Antagonist-bound Estrogen Receptors
J. Biol. Chem., April 6, 2007; 282(14): 10449 - 10455.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. Folkertsma, P. I. van Noort, A. de Heer, P. Carati, R. Brandt, A. Visser, G. Vriend, and J. de Vlieg
The Use of in Vitro Peptide Binding Profiles and in Silico Ligand-Receptor Interaction Profiles to Describe Ligand-Induced Conformations of the Retinoid X Receptor {alpha} Ligand-Binding Domain
Mol. Endocrinol., January 1, 2007; 21(1): 30 - 48.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Albers, B. Blume, T. Schlueter, M. B. Wright, I. Kober, C. Kremoser, U. Deuschle, and M. Koegl
A Novel Principle for Partial Agonism of Liver X Receptor Ligands: COMPETITIVE RECRUITMENT OF ACTIVATORS AND REPRESSORS
J. Biol. Chem., February 24, 2006; 281(8): 4920 - 4930.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. Tamrazi, K. E. Carlson, A. L. Rodriguez, and J. A. Katzenellenbogen
Coactivator Proteins as Determinants of Estrogen Receptor Structure and Function: Spectroscopic Evidence for a Novel Coactivator-Stabilized Receptor Conformation
Mol. Endocrinol., June 1, 2005; 19(6): 1516 - 1528.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
M. S. Ozers, K. M. Ervin, C. L. Steffen, J. A. Fronczak, C. S. Lebakken, K. A. Carnahan, R. G. Lowery, and T. J. Burke
Analysis of Ligand-Dependent Recruitment of Coactivator Peptides to Estrogen Receptor Using Fluorescence Polarization
Mol. Endocrinol., January 1, 2005; 19(1): 25 - 34.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society